SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-047560
Filing Date
2024-04-24
Accepted
2024-04-24 16:01:23
Documents
56
Period of Report
2024-04-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrv-20240424.htm   iXBRL 8-K 54273
2 EX-99.1 acrv-ex99_1.htm EX-99.1 34636
3 EX-99.2 acrv-ex99_2.htm EX-99.2 26317
4 GRAPHIC img29235008_0.jpg GRAPHIC 16059
5 GRAPHIC acrv-ex99_1s1.jpg GRAPHIC 288414
6 GRAPHIC acrv-ex99_1s2.jpg GRAPHIC 613548
7 GRAPHIC acrv-ex99_1s3.jpg GRAPHIC 217844
8 GRAPHIC acrv-ex99_1s4.jpg GRAPHIC 396631
9 GRAPHIC acrv-ex99_1s5.jpg GRAPHIC 517516
10 GRAPHIC acrv-ex99_1s6.jpg GRAPHIC 516116
11 GRAPHIC acrv-ex99_1s7.jpg GRAPHIC 202313
12 GRAPHIC acrv-ex99_1s8.jpg GRAPHIC 493301
13 GRAPHIC acrv-ex99_1s9.jpg GRAPHIC 657926
14 GRAPHIC acrv-ex99_1s10.jpg GRAPHIC 469885
15 GRAPHIC acrv-ex99_1s11.jpg GRAPHIC 366817
16 GRAPHIC acrv-ex99_1s12.jpg GRAPHIC 309071
17 GRAPHIC acrv-ex99_1s13.jpg GRAPHIC 339750
18 GRAPHIC acrv-ex99_1s14.jpg GRAPHIC 344260
19 GRAPHIC acrv-ex99_1s15.jpg GRAPHIC 646632
20 GRAPHIC acrv-ex99_1s16.jpg GRAPHIC 351975
21 GRAPHIC acrv-ex99_1s17.jpg GRAPHIC 269188
22 GRAPHIC acrv-ex99_1s18.jpg GRAPHIC 326826
23 GRAPHIC acrv-ex99_1s19.jpg GRAPHIC 361432
24 GRAPHIC acrv-ex99_1s20.jpg GRAPHIC 382828
25 GRAPHIC acrv-ex99_1s21.jpg GRAPHIC 327751
26 GRAPHIC acrv-ex99_1s22.jpg GRAPHIC 193690
27 GRAPHIC acrv-ex99_1s23.jpg GRAPHIC 514724
28 GRAPHIC acrv-ex99_1s24.jpg GRAPHIC 687188
29 GRAPHIC acrv-ex99_1s25.jpg GRAPHIC 564377
30 GRAPHIC acrv-ex99_1s26.jpg GRAPHIC 290566
31 GRAPHIC acrv-ex99_1s27.jpg GRAPHIC 445154
32 GRAPHIC acrv-ex99_1s28.jpg GRAPHIC 907862
33 GRAPHIC acrv-ex99_1s29.jpg GRAPHIC 527121
34 GRAPHIC acrv-ex99_1s30.jpg GRAPHIC 336940
35 GRAPHIC acrv-ex99_1s31.jpg GRAPHIC 300458
36 GRAPHIC acrv-ex99_1s32.jpg GRAPHIC 268509
37 GRAPHIC acrv-ex99_1s33.jpg GRAPHIC 430265
38 GRAPHIC acrv-ex99_1s34.jpg GRAPHIC 354717
39 GRAPHIC acrv-ex99_1s35.jpg GRAPHIC 483992
40 GRAPHIC acrv-ex99_1s36.jpg GRAPHIC 382571
41 GRAPHIC acrv-ex99_1s37.jpg GRAPHIC 545089
42 GRAPHIC acrv-ex99_1s38.jpg GRAPHIC 410220
43 GRAPHIC acrv-ex99_1s39.jpg GRAPHIC 252382
44 GRAPHIC acrv-ex99_1s40.jpg GRAPHIC 476545
45 GRAPHIC acrv-ex99_1s41.jpg GRAPHIC 235562
46 GRAPHIC acrv-ex99_1s42.jpg GRAPHIC 112862
  Complete submission text file 0000950170-24-047560.txt   23881818

Data Files

Seq Description Document Type Size
47 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acrv-20240424.xsd EX-101.SCH 45629
59 EXTRACTED XBRL INSTANCE DOCUMENT acrv-20240424_htm.xml XML 5794
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41551 | Film No.: 24870490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)